Kerstin M. Gustafsson

Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays

Andreas Hillarp, Fariba Baghaei, Inger Fagerberg Blixter et al. · Journal of Thrombosis and Haemostasis · 2010 · 281 citations · Full text

Thrombosis, Coagulation Assays, Hematology +8

Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays

Fariba Baghaei, Inger Fagerberg Blixter, Kerstin M. Gustafsson et al. · Thrombosis and Haemostasis · 2010 · 264 citations · Full text

Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays

Andreas Hillarp, Kerstin M. Gustafsson, Lars Faxälv et al. · Journal of Thrombosis and Haemostasis · 2014 · 114 citations · Full text

Thrombosis, Anti‐fxa Assays, Medicine +9

More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate

Tomas Lindahl, Maria Wallstedt, Kerstin M. Gustafsson et al. · Thrombosis Research · 2015 · 35 citations · Full text

Thrombosis, Efficient Reversal, Medicine +8

Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle

Roza Chaireti, Kerstin M. Gustafsson, Birgitta Byström et al. · Human Reproduction · 2013 · 27 citations